CURRICULUM VITAE. Key Qualifications: Internal Medicine Specialist and Medical oncologist. Name of Hospital: Firat Universitesi Hastanesi

Size: px
Start display at page:

Download "CURRICULUM VITAE. Key Qualifications: Internal Medicine Specialist and Medical oncologist. Name of Hospital: Firat Universitesi Hastanesi"

Transcription

1 CURRICULUM VITAE Personal Details Surname: Elkiran First Name: Emin Tamer Akademic title/ position: Associate professor of Medicine Key Qualifications: Internal Medicine Specialist and Medical oncologist Research Interest: Solid and hematologic malignancies International Experience/Collaborations: Contact Details: Work Address: Name of Hospital: Firat Universitesi Hastanesi Street: Universite Mahallesi Town: Elazig Country:Turkey Post Code: Phone/Fax: /Ext: Date of Birth: Place and Country of Birth: Hekimhan-Malatya-Turkey Country of Citizenship: The Republic of Turkey Country of Training: Turkey First Language: Turkish Languages: English Akademic Details

2 Faculty/University ( name and address) Date of Graduation:1993 Ankara University Faculty of Medicine- Ankara-Turkey Postgraduate Training: ( Name and address of Center and Supervisor [s] in charge of Training) 1-Cukurova University Faculty of Medicine, Department of Internal Medicine-Adana-Turkey 2-Hacettepe University Faculty of Medicine, Department of Medical Oncology-Ankara- Turkey SUPERVISOR IN CHARGE OF TRAINING: From To Title of thesis: 1-Spontaneous ascite infection in cirrhotic patient, (Thesis of internal medicine) 2-Retrospective analysis of osteosarcoma patients, (Thesis of medical oncology) Accreditation: (Name, number and date of certificate issued by Universty, Medical Association or Government Body) Academic Experience: Cukurova University Faculty of Medicine, Department of Internal Medicine-Adana-Turkey 2-Hacettepe University Faculty of Medicine, Department of Medical Oncology Cukurova University Faculty of Medicine, Department of Internal Medicine Dec 1993-June 1998 Adana Karaisali Hospital June 1998-April 1999 Firat University Faculty of Medicine, Department of Internal Medicine April 1999-June 1999 Ankara University Faculty of Medicine, Department of Hematology June 1999-Augus 1999 Firat University Faculty of Medicine, Department of Internal Medicine Sep 1999-Oct 2001 Hacettepe University Faculty of Medicine, Department of Medical Oncology Oct Oct 2004 Firat University Faculty of Medicine, Department of Internal Medicine Since Oct 2004 Memberships: 1- Society of Medical Oncology 2-Anatolian Society of Medical Oncology

3 3-Turkish Society of Hematology 4-Turkish Oncology Group International Publications 1. Elkiran, E. T., K. Altundag, S. Aksoy, I. K. Onal and G. Tekuzman, Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma, Am. J. Hematol, 75, 265 (2004). 2. Altundag, K., E. T. Elkiran and O. Altundag, Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma, Cancer, 100, (2004). 3. Altundag, K., O. Altundag, E. T. Elkiran, M. Cengiz and Y. Ozisik, Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells, Med. Hypotheses, 63, (2004). 4. Babaoglu, M. O., O. Karadag, Y. Saikawa, K. Altundag, T. Elkiran, U. Yasar and A. Bozkurt, Hepatotoxicity due to a possible ınteraction between cytosine arabinoside and dipyridamole: a case report, Eur. J. Clin. Pharmacol, 60, (2004). 5. Ozcakar, L., O. Karadag, M. Isik, E. T. Elkiran, O, Dikbas and K, Altundag, Progressive ascending paraparesia in an acute lymphoblastic leukemia patient: masked but not fallacious, J. Exp. Clin. Cancer Res, 23, (2004). 6. Karadag, O., M. O. Babaoglu, K. Altundag, T. Elkiran, U. Yasar and A. Bozkurt, 5- Fluorouracil-induced coronary spasm: may inhibition of hyperpolarization factors produced by CYP2C enzymes be the cause?, Oncology, 66, (2004). 7. Elkiran, E. T., K. Altundag, Y. Beyazit, N. Guler and A. Kars, Fluorouracil-induced neurotoxicity presenting with generalized tonic-clonic seizure, Ann. Pharmacother, 38, 2171 (2004). 8. Karadag, O., K. Altundag, E. T. Elkiran, O. Dikbas, G. Gedikoglu and A. Kars, Anterior abdominal wall synovial sarcoma: a rare presentation, Am. J. Clin. Oncol, 28, (2005). 9. Kurt, M., I. K. Onal, T. Elkiran, B. Altun, K. Altundag and I. Gullu, Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma, Med. Oncol, 22, (2005). 10.Kurt, M. A. Shorbagi, K. Altundag, T. Elkiran, I. Gullu and E. Kansu, Possible association between budd-chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia, Am. J. Hematol, 80, (2005).

4 11. Elkiran, E. T., B. Aygen, A. Karaoglu and K. Altundag, Metastatic osteosarcoma to the brain in adult patient, J. Neurooncol, 76, 213 (2006). 12. Elkiran, T., H. Harputluoglu, U. Yasar, M. O. Babaoglu, A.K. Dincel, K. Altundag, Y. Ozisik, N. Guler and A. Bozkurt, Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients, Methods Find. Exp. Clin. Pharmacol., 29, (2007). 13. Elkiran, E. T., H. Abali, S. Aksoy, K. Altundag, M. Erman, A. Kars, A. Turker, G. Tekuzman and Y. Ozisik, Thymic epithelial neoplasia: a study {Okumura, Ohta, et al /id}of 58 cases, Med. Onco., 24, (2007). 14. Elkiran, E. T., Mar, N., Aygen, B., Gursu, F., Karaoglu, A. and Koca, S. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population BMC Cancer, 7, 48, (2007). 15. Aydin, S., Geckil, H., Karaoglu, A., and Elkiran, E. T. Ghrelin: a novel peptide with therapeutic effect in certain cancers? Med Hypotheses, 69, , (2007). 16. Ozcakar, L., Elkiran, T., Altundag, K., and Tayfur, O. A fortuitous episode of brachial plexopathy in a patient with metastatic breast cancer Surg Neurol, 69, (2008 ). Presentations at International Scientific Meetings 1. Çeliker, H., B. Elkıran, Đ. H. Behçecioğlu, A. Demir and E. T. Elkıran, Yeni tanı almış kronik böbrek yetmezliği hastalarında endoskopik bulgular, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 217, Đzmir, Çeliker, H., B. Elkıran, E. T. Elkıran, Đ. H. Behçecioğlu and A. Demir, Kronik böbrek yetmezliği hastalarında hepatobiliyer değişiklikler, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 218, Đzmir, Çeliker, H., B. Elkıran, N. Đlhan, A. Var and E. T. Elkıran, Hemodializ ve periton diyalizinin oksidatif stres parametrelerinin üzerine etkileri, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Đzmir, Đlhan, N., A. Var, H. Çeliker, B. Elkıran and E. T. Elkıran, Hemodializ hastalarında oksidan ve antioksidan parametreler üzerine yaş ve cinsiyetin etkisi, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 225, Đzmir, 1999.

5 5. Elkıran, B., H. Çeliker, E. T. Elkıran, A. Var and N. Đlhan, Hemodializ hastalarında oksidatif stres üzerine trimetazine in etkileri, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 226, Đzmir, Çeliker, H., B. Elkıran, E. T. Elkıran and A. Đ. Günal, Üremik hastalarda depresyon, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 272, Đzmir, Var, A., N. Đlhan, H. Çeliker, B. Elkıran and E. T. Elkıran, Değişik membran tiplerin oksidan-antioksidan sistem parametreleri üzerine etkileri, IVth Congress of Balkan cities association of nephrology, dialysis, transplantation and artificial organs. XVI. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, 276, Đzmir, Abali, H., A. Türker, B. Öksüzoglu, T. Elkiran, M. Erman, Y. Ozişik and A. Kars, Primitive neuroectodermal tumor and Ewings sarcoma: Experience in adults at a tertiary care hospital, 27 th ESMO Congress, Nice, France, Annals of Oncology, Vol. 13, , Elkiran, T., B. Oyan, Y. Koç, A. Kars, A. Türker, F. Tekin, Y. Cetinkaya, O. Uzun, M. Akova, S. Unal, G. Tekuzman and E. Kansu, Infection complications during nonmyeloablative allogenic transplantation, XVII th Meeting Of The International Society Of Hematology (European & African Divison), Graz, Austria, 60, Aksoy, S., H. Abali, S. Kiliçkap, O. Yavas, B. Oyan, E. T. Elkiran, T. Aras, O. Ugurlu, N. Güler and G. Tekuzman, Outcome of well differentiated thyroid cancer: Single institution results 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition), J. Clin. Oncology, Vol. 22, 5615, Aygen, B., E. T. Elkıran, A. Karaoğlu and N. Akpolat, An unusual tumor of the renal pelvis: primary mucinous adenocarcinoma. A case report, XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul-Turkey, 282, Elkiran, T., N. Akpolat and B. Aygen, Extraskeletal osteosarcoma of the gluteal region: Case Report, XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul- Turkey, 265, Elkiran, T., B. Aygen and H. Yekeler, A case of bone marrow necrosis as the etiology of severe pancytopenia XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul-Turkey, 224, Elkiran, E. T., S. Çelebi, B. Aygen, A. Karaoğlu and I. Özercan, Primary malignant melanoma of esophagogastric junction: A case report, XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul-Turkey, 203, Elkiran, E. T., B. Aygen and Özercan I, A rare case of primary squamous cell carcınoma of the breast in a young woman, XXIII. World Congress of Pathology and Laboratory Medicine, Đstanbul-Turkey, 142, 2005.

6 16. Elkıran, E. T. and B. Aygen, Simultaneous occurrence of Hodgkin Lymphoma and tuberculosis: A case report, XXX th World Congress of the International Society of Hematology Đstanbul, Turkish Journal of Haematology (Supplement), Vol. 22, 178, Elkıran, T. and B. Aygen, Dental Filling: Cause of eosinophilia, XXX th World Congress of the International Society of Hematology, Đstanbul, Turkish Journal of Haematology (Supplement), Vol. 22, 204, Elkiran, E. T., K. Altundag, M. O. Babaoglu, U. Yasar, Y. Ozisik, N. Guler, A. Kara Dincel, and A. Bozkurt, Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide / adriamycin administration in operable breast cancer patients 2005 ASCO Annual Meeting Proceedings, J. Clin. Oncology, Vol. 23, No. 16S, Elkiran, E. T., N. Mar, B. Aygen, Gursu F, Koca S and A. Karaoglu, Serum paraoxonase activity changes in patients with lung cancer, 31 st ESMO Congress, Đstanbul, Turkey, Annals of Oncology, Vol. 17, ix253, Elkiran, E. T., A, Türker, A. Kars, H. Harputluoglu, M. Erman, G. Gedikoglu and G. Tekuzman, Retrospektive evaluation of osteosarcomas of the extremity in adults, 31 st ESMO Congress, Đstanbul, Turkey, Annals of Oncology, Vol. 17, ix166, 2006.

CURRICULUM VITAE. Research Interest: Bresat Cancer, Gyneocologic Cancer, Colorectal Cancer, Lung Cancer.

CURRICULUM VITAE. Research Interest: Bresat Cancer, Gyneocologic Cancer, Colorectal Cancer, Lung Cancer. CURRICULUM VITAE Personal Details Surname: KARAOGLU First Name: Aziz Akademic title/ position: Asscociate Proffessor Key Qualifications: -Internal Medicine, -Medical Oncology Research Interest: Bresat

More information

4-Deveci F, Akbulut HH, Çelik I, Muz MH Ilhan F. Lymphocyte Subpopulations in Pulmonary Tuberculosis Patients, Mediators Inflamm., 2006;(2);89070.

4-Deveci F, Akbulut HH, Çelik I, Muz MH Ilhan F. Lymphocyte Subpopulations in Pulmonary Tuberculosis Patients, Mediators Inflamm., 2006;(2);89070. CURRICULUM VITAE Personal Details Surname: Muz Frst Name: Mehmet Hamdi Academic title/position: Prof. Dr.- President of Chest Disease Departmant Key Qualifcations: Research Interest: Lung Cancers Đnternational

More information

CURRICULUM VITAE. Personal Details. Surname: Akbulut. Frst Name: Hatice Handan. Academic title/position: Prof, Departmant of Immunology

CURRICULUM VITAE. Personal Details. Surname: Akbulut. Frst Name: Hatice Handan. Academic title/position: Prof, Departmant of Immunology CURRICULUM VITAE Personal Details Surname: Akbulut Frst Name: Hatice Handan Academic title/position: Prof, Departmant of Immunology Key Qualifcations: Research Interest: IFA, Flow cytometry, Evaluation

More information

SUPERVĐSOR ĐN CHARGE OF TRAINING: Şef Dr Kunter Perim

SUPERVĐSOR ĐN CHARGE OF TRAINING: Şef Dr Kunter Perim CURRICULUM VITAE Personal Details Surname: Deveci First Name: Figen Academic title/position: Prof, Departmant of Chest Disease Key Qualifcations: Research Interest: Asthma Bronchiale Đnternational Experience/Collaborations:

More information

New Hampshire Childhood Cancer

New Hampshire Childhood Cancer Introduction: New Hampshire Childhood Cancer New Hampshire, Childhood Cancer, January 2009 Issue Brief Cancer in children is relatively uncommon, impacting fewer than twenty two of every 100,000 children

More information

Immunohistochemical differentiation of metastatic tumours

Immunohistochemical differentiation of metastatic tumours Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in

More information

What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals

What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application

More information

Pediatric Oncology for Otolaryngologists

Pediatric Oncology for Otolaryngologists Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department

More information

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted

More information

Medical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA

Medical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA THE UNIVERSITY OF BRITISH COLUMBIA Department of Urologic Sciences Faculty of Medicine Gordon & Leslie Diamond Health Care Centre Level 6, 2775 Laurel Street Vancouver, BC, Canada V5Z 1M9 Tel: (604) 875-4301

More information

What is a Stem Cell Transplantation?

What is a Stem Cell Transplantation? What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am

More information

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer

More information

A Career in Pediatric Hematology-Oncology? Think About It...

A Career in Pediatric Hematology-Oncology? Think About It... A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T

More information

FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E. Özer (TR) - S.A.Raptis (GR)

FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E. Özer (TR) - S.A.Raptis (GR) FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 1 st TURKISH-HELLENIC POSTGRADUATE CONTINUOUS MEDICAL EDUCATION MEETING MAY 6-9, 2011, IZMIR, TURKEY DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E.

More information

CURRICULUM VITAE. Personal Details. Surname: Isik. First Name: Ahmet. Akademic title/ position: Professor of Medicine

CURRICULUM VITAE. Personal Details. Surname: Isik. First Name: Ahmet. Akademic title/ position: Professor of Medicine CURRICULUM VITAE Personal Details Surname: Isik First Name: Ahmet Akademic title/ position: Professor of Medicine Key Qualifications: Internal Medicine Specialist and Romatologist Research Interest: International

More information

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also

More information

MEDICAL POLICY POLICY TITLE

MEDICAL POLICY POLICY TITLE Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): Effective Date: April 15, 2008 July 1, 2009- RETIRED I. DESCRIPTION/BACKGROUND High dose chemotherapy (HDC) involves the administration

More information

Oncology Central MEDIA PACK 2016 SPONSORSHIP ADVERTISING NETWORKING

Oncology Central MEDIA PACK 2016 SPONSORSHIP ADVERTISING NETWORKING Oncology Central MEDIA PACK 2016 SPONSORSHIP ADVERTISING NETWORKING Client opportunities CONTENTS About us...02 Readership...04 Driving qualified leads...05 Our Journals...08 Editorial Calendar...10 Rate

More information

Role of clinical trials in professional development

Role of clinical trials in professional development Role of clinical trials in professional development Peeter Padrik Tartu University Hospital University of Tartu Estonian Society for Medical Oncology How we do treatment decisions? Personal experience?

More information

XIV ANNUAL MEETING OF NURSING

XIV ANNUAL MEETING OF NURSING Archive of Oncology 2000;8(Suppl 1):69. SESSION 5 XIV ANNUAL MEETING OF NURSING 69 Archive of Oncology 2000;8(Suppl 1):70. 70 UDC: 616.34-007.272:616-089.8:614.39 I. GAJI M. ULAFI Æ. MIHAJLOVI R. NE I

More information

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Chapter Sixteen Oncology bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o Combining Forms Prefixes and Suffixes Carcinogenesis anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Causes of cancer

More information

CURRICULUM VITAE. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system

CURRICULUM VITAE. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system CURRICULUM VITAE Personal Details Surname: BAHCECIOGLU First Name: Ibrahim Halil Akademic title/ position: Prof. Dr. Key Qualifications: Gastroenterology, Hepatology, Pancreatobiliary system Research Interest:

More information

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion. Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case

More information

CURRICULUM VITAE. Paul Magnus Schneider, M.D. Professor of Surgery

CURRICULUM VITAE. Paul Magnus Schneider, M.D. Professor of Surgery CURRICULUM VITAE Paul Magnus Schneider, M.D. Professor of Surgery OFFICE Department of Visceral and Transplantation Surgery University Hospital Zurich CH-8008 Zurich Switzerland phone: +41-(0)44-2559723

More information

Second Cancers in Adults

Second Cancers in Adults Second Cancers in Adults This document focuses on second cancers in adults. For information about second cancers after treatment of childhood cancers, see our document Children Diagnosed With Cancer: Late

More information

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of

More information

A Framework of Competences for the Level 3 Training Special Study Module in Paediatric Oncology

A Framework of Competences for the Level 3 Training Special Study Module in Paediatric Oncology A Framework of Competences for the Level 3 Training Special Study Module in Paediatric Oncology Feb 2010 Royal College of Paediatrics and Child Health www.rcpch.ac.uk Royal College of Paediatrics and Child

More information

CAR T cell therapy for lymphomas

CAR T cell therapy for lymphomas CAR T cell therapy for lymphomas Sattva S. Neelapu, MD Associate Professor and Deputy Chair ad interim Department of Lymphoma and Myeloma UT MD Anderson Cancer Center, Houston, TX CAR T cell therapy What

More information

Site Specific Oncology Clinical Enrichment Brochure for non-ui Hospitals and Clinics staff

Site Specific Oncology Clinical Enrichment Brochure for non-ui Hospitals and Clinics staff University of Iowa Hospitals and Clinics Services and Patient Care Nursing Clinical Education Center 4 West, General Hospital 319-356-4304 Tel Nursing CEU Credit: CEUs will be granted by UIHC (IBN Approved

More information

EDUCATIONAL STATUS & DEGREES

EDUCATIONAL STATUS & DEGREES CURRICULUM VITAE Fatma ÇELİK, MSc Adress: Hacettepe Universitesi, Saglik Bilimleri Fakultesi, Beslenme ve Diyetetik Bolumu, D-blok 06100 Sihhiye/Ankara Telephone : +90 (0312) 3051094-152 E-mail: fatma.celik@hacettepe.edu.tr

More information

SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.

SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR. SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR. TRACEY O CONNOR RESEARCH QUESTON Patients with previously diagnosed hematologic

More information

Interesting Case Series. Periorbital Richter Syndrome

Interesting Case Series. Periorbital Richter Syndrome Interesting Case Series Periorbital Richter Syndrome MarkGorman,MRCS,MSc, a Julia Ruston, MRCS, b and Sarath Vennam, BMBS a a Division of Plastic Surgery, Royal Devon and Exeter Hospital, Exeter, Devon,

More information

Lung Cancer: More than meets the eye

Lung Cancer: More than meets the eye Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research

More information

Metastatic Breast Cancer 201. Carolyn B. Hendricks, MD October 29, 2011

Metastatic Breast Cancer 201. Carolyn B. Hendricks, MD October 29, 2011 Metastatic Breast Cancer 201 Carolyn B. Hendricks, MD October 29, 2011 Overview Is rebiopsy necessary at the time of recurrence or progression of disease? How dose a very aggressive treatment upfront compare

More information

Cancer in Children. What is cancer?

Cancer in Children. What is cancer? What is cancer? Cancer in Children The body is made up of trillions of living cells. Normal body cells grow, divide to make new cells, and die in an orderly fashion. During the early years of a person

More information

Cancer of the Cardia/GE Junction: Surgical Options

Cancer of the Cardia/GE Junction: Surgical Options Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD

More information

BONE MARROW FAILURE DISEASE SYMPOSIUM SATURDAY SEPTEMBER 27, 2014 AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT

BONE MARROW FAILURE DISEASE SYMPOSIUM SATURDAY SEPTEMBER 27, 2014 AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT SATURDAY SEPTEMBER 27, 2014 THE HOTEL HERSHEY 100 Hotel Road, Hershey, PA 17033 BONE MARROW FAILURE DISEASE SYMPOSIUM AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT A CONTINUING EDUCATION SERVICE OF

More information

Mayo Clinic College of Medicine Pharmacy Services. Rotation Summary

Mayo Clinic College of Medicine Pharmacy Services. Rotation Summary Mayo Clinic College of Medicine Pharmacy Services Rotation Summary Rotation Title: PGY-2 Pediatric Hematology-Oncology Rotation Length: 3-6 weeks Primary Preceptor Name: Amanda Kuper, PharmD, BPCS, Ron

More information

Resumen Curricular de los Profesores. Jesse Boehm

Resumen Curricular de los Profesores. Jesse Boehm Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub

More information

Role of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases

Role of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases Role of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases R. Shraddha, P.N. Pandit Radium Institute, Patna Medical College and Hospital, Patna, India Abstract NHL is a highly

More information

CURRICULUM VITAE. Personal Details. Surname: OZDEN First name: Mehmet Academic title/position: Assoc. Prof. Key Qualifications: Infection Immunology

CURRICULUM VITAE. Personal Details. Surname: OZDEN First name: Mehmet Academic title/position: Assoc. Prof. Key Qualifications: Infection Immunology CURRICULUM VITAE Personal Details Surname: OZDEN First name: Mehmet Academic title/position: Assoc. Prof. Key Qualifications: Infection Immunology Research Interest: Infectious Diseases International Experience/Collaborations:

More information

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia

More information

Small Cell Lung Cancer

Small Cell Lung Cancer Small Cell Lung Cancer Lung Practice Guideline Dr. Brian Dingle MSc, MD, FRCPC Approval Date: April 2007 Revised: November 2008 This guideline is a statement of consensus of the Thoracic Disease Site Team

More information

POLICY A. INDICATIONS

POLICY A. INDICATIONS Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below

More information

National Pharmaceutical Pricing Authority 3 rd Floor, YMCA Cultural Centre 1 Jai Singh Road New Delhi 110001 File No. 23(01)2014/Div.

National Pharmaceutical Pricing Authority 3 rd Floor, YMCA Cultural Centre 1 Jai Singh Road New Delhi 110001 File No. 23(01)2014/Div. Dated 21 st November 2014 NPPA Invites Comments of Pharmaceutical Industry & Trade, Consumer Organisations, Public Health Experts and other Stakeholders on the Recommendations of Tata Memorial Centre under

More information

1998-2004 Medical Faculty Hacettepe University Faculty of Medicine (English Section) Ankara

1998-2004 Medical Faculty Hacettepe University Faculty of Medicine (English Section) Ankara PERSONAL INFORMATION: Name: Surname: Umut Sinan ERSOY Birth Date: June 16 th, 1981 Birth Place: Natioanality: Marital Status: Title: Adana, Turkey Republic of Turkey Single Medical Doctor Work Address:

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,

More information

CURRICULUM VITAE. Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology

CURRICULUM VITAE. Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology CURRICULUM VITAE Personal Details Surname: Akbulut First Name: Mehmet Academic title/position: Professor Key Qualifications: Clinicaly Cardiology, Invasive Cardiology, Cardiac Electrophisology Research

More information

Co-pay assistance organizations offering assistance

Co-pay assistance organizations offering assistance Acromegaly Acute Exacerbations of Multiple Sclerosis Acute Porphyrias Advanced Idiopathic Parkinson' s Disease Age-Related Macular Degeneration www.theassistancefund.org Alcohol Dependence Alpha-1 Antitrypsin

More information

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc. Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied

More information

Bone Marrow/Stem Cell Transplant

Bone Marrow/Stem Cell Transplant Blue Distinction Centers for Transplants Program Selection Criteria for 2010 Mid-Point Designations To qualify as a Blue Distinction Center for Transplants (), each facility must satisfy s quality based

More information

Course Curriculum for Master Degree in Clinical Pharmacy

Course Curriculum for Master Degree in Clinical Pharmacy Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon

More information

For personal use only

For personal use only The Company Announcements Platform ASX Limited By E-lodgement PTX Shareholder Newsletter 9 November 2015, Melbourne, Australia: Prescient Therapeutics Limited (ASX: PTX), a clinical stage oncology company,

More information

CANCER TREATMENT: Chemotherapy

CANCER TREATMENT: Chemotherapy CANCER TREATMENT: Chemotherapy Chemotherapy, often called chemo, is the use of drugs to treat a disease. The term chemotherapy is now most often used to describe a type of cancer treatment. Dr. Khuri:

More information

information for payers and referrers

information for payers and referrers a d u lt s t e m c e l l t r a n s p l a n tat i o n p r o g r a m information for payers and referrers Spring 2014 For more information, visit www.dfbwcc.org/bmt. o u r expertise Since its founding in

More information

Umbilical Cord Blood Stem Cells Current Status & Future Potential

Umbilical Cord Blood Stem Cells Current Status & Future Potential Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: natasha.ali@aku.edu

More information

Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in

Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition, 2001 Vagina Jeffrey L. Stern, MD Carcinoma of the vagina is

More information

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each Introduction 1.1 Introduction: About 10,500 new cases of acute myelogenous leukemia are diagnosed each year in the United States (Hope et al., 2003). Acute myelogenous leukemia has several names, including

More information

CURRICULUM VITAE. International Experience/Collaborations: Wadsworth Center, State University, Albany, New York, USA

CURRICULUM VITAE. International Experience/Collaborations: Wadsworth Center, State University, Albany, New York, USA CURRICULUM VITAE Personal Details Surname: Bulut First Name: Yasemin Academic title/position: Associate Professor Key Qualifications: Laboratory diagnosis of viral diseases Epidemiology of viral infection

More information

E UROPEAN CURRICULUM VITAE FORMAT

E UROPEAN CURRICULUM VITAE FORMAT E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Address VALENTINA GUARNERI University of Padova Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche Istituto Oncologico Veneto

More information

False positive PET in lymphoma

False positive PET in lymphoma False positive PET in lymphoma Thomas Krause Introduction and conclusion 2 3 Introduction 4 FDG-PET in staging of lymphoma 34 studies with 2227 Patients CT FDG-PET Sensitivity 63 % 89 % (58%-100%) (63%-100%)

More information

Pathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France

Pathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France Pathophysiology of bone metastasis : how does it apply to pain treatment in palliative care? JP Vuillez, Grenoble, France Bone metastases 70 % of prostate and breast cancers 30 % of lung, bladder and thyroid

More information

Feline Lymphoma Chemotherapy and Chemotherapy Protocols

Feline Lymphoma Chemotherapy and Chemotherapy Protocols Feline Lymphoma Chemotherapy and Chemotherapy Protocols If you have reached this page, your cat probably has a definite diagnosis of feline lymphoma from your veterinarian. The information below is not

More information

White Paper. Understanding the Scope and Challenges of Childhood Cancer. Introduction

White Paper. Understanding the Scope and Challenges of Childhood Cancer. Introduction White Paper Understanding the Scope and Challenges of Childhood Cancer Introduction Imagine a world without childhood cancer. No painful chemotherapy treatments. No emotional stress on children and their

More information

GRANIX (tbo-filgrastim)

GRANIX (tbo-filgrastim) RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil

More information

microrna Signatures in Cancer E. ROBERT WASSMAN, MD, FAAP, FACMG CHIEF MEDICAL OFFICER, ROSETTA GENOMICS

microrna Signatures in Cancer E. ROBERT WASSMAN, MD, FAAP, FACMG CHIEF MEDICAL OFFICER, ROSETTA GENOMICS microrna Signatures in Cancer E. ROBERT WASSMAN, MD, FAAP, FACMG CHIEF MEDICAL OFFICER, ROSETTA GENOMICS 1st International Congress on Controversies in Personalized Oncology (CONPO) BARCELONA, SPAIN MARCH

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

Stem Cell Transplantation

Stem Cell Transplantation Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance

More information

The Blood Cancer Twice As Likely To Affect African Americans: Multiple Myeloma

The Blood Cancer Twice As Likely To Affect African Americans: Multiple Myeloma The Blood Cancer Twice As Likely To Affect African Americans: Multiple Myeloma 11 th Annual National Leadership Summit on Health Disparities Innovation Towards Reducing Disparities Congressional Black

More information

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014 ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the

More information

Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC) Abhishek Vadalia Introduction Chemoembolization is being used with increasing frequency in the treatment of solid hepatic tumors such as Hepatocellular Carinoma (HCC) & rare Cholangiocellular Carcinoma

More information

Veterinary Oncology: The Lumps We Hate To Treat

Veterinary Oncology: The Lumps We Hate To Treat Veterinary Oncology: The Lumps We Hate To Treat Michelle Turek, DVM, DACVIM (Oncology), DACVR (Radiation Oncology) College of Veterinary Medicine University of Georgia Athens, GA Veterinary Oncology Veterinary

More information

METROPOLITAN LIFE INSURANCE COMPANY 200 PARK AVENUE, NEW YORK, NEW YORK 10166-0188

METROPOLITAN LIFE INSURANCE COMPANY 200 PARK AVENUE, NEW YORK, NEW YORK 10166-0188 METROPOLITAN LIFE INSURANCE COMPANY 200 PARK AVENUE, NEW YORK, NEW YORK 10166-0188 POLICYHOLDER: NORFOLK PUBLIC SCHOOLS Group Policy Form No: GPNP04-CI (Referred to herein as the Group Policy ) Certificate

More information

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

This module consists of four units which will provide the user a basic knowledge of cancer as a disease. Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define

More information

Childhood Cancer in the Primary Care Setting

Childhood Cancer in the Primary Care Setting Childhood Cancer in the Primary Care Setting Mohamed Radhi, M.D. Associate Professor, UMKC Pediatric Hematology/Oncology/BMT Children s Mercy Hospital I will discuss: Overview of childhood cancer Presentation

More information

OPTIONAL Group Critical Illness For peace of mind

OPTIONAL Group Critical Illness For peace of mind OPTIONAL Group Critical Illness For peace of mind A Critical Illness Program for the members of: The Ontario Dental Hygienists Association Administered by: LMS PROLINK Ltd. 1 ACE INA Life Insurance Guaranteed

More information

Asst. Prof. Kerem OK Işık University Facult of Arts and Sciences Department of Information Technologies kerem.ok@isikun.edu.tr

Asst. Prof. Kerem OK Işık University Facult of Arts and Sciences Department of Information Technologies kerem.ok@isikun.edu.tr Asst. Prof. Kerem OK Işık University Facult of Arts and Sciences Department of Information Technologies kerem.ok@isikun.edu.tr 1. Name Surname : Kerem OK 2. Birth Date : 02.11.1984 3. Academic Title :

More information

News Release. Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma

News Release. Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma Your Contacts News Release Merck KGaA, Darmstadt, Germany Media: Markus Talanow +49 6151 72 7144 Investor Relations +49 6151 72 3321 Pfizer Inc., New York, USA Media: Sally Beatty +1 212 733 6566 Investor

More information

Cytopathology Case Presentation #8

Cytopathology Case Presentation #8 Cytopathology Case Presentation #8 Emily E. Volk, MD William Beaumont Hospital, Troy, MI Jonathan H. Hughes, MD Laboratory Medicine Consultants, Las Vegas, Nevada Clinical History 44 year old woman presents

More information

Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer

Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer Your Certified Professional Cancer Coach An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer The CPCC Patient Program Nutrition & Lifestyle Oncology A Cancer Diagnosis

More information

Critical Illness Supplemental Insurance

Critical Illness Supplemental Insurance You ve protected your family s financial future by purchasing life and health insurance. Critical Illness Supplemental Insurance It s cash when you need it. You choose how to spend it. So you can focus

More information

June 27, 2015 Radisson Blu Hotel Sisli - Istanbul

June 27, 2015 Radisson Blu Hotel Sisli - Istanbul 5 June 27, 2015 Radisson Blu Hotel Sisli - Istanbul INVITATION On behalf of the Turkish Medical Oncology Society Executive Committee, it th is my pleasure to invite you to join the 6 ASCO-licensed "Best

More information

THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS

THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.

More information

Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae

Ariela Benigni. Biol.Sci.D., Ph.D. Curriculum Vitae Ariela Benigni Biol.Sci.D., Ph.D. Curriculum Vitae Personal Data Name: Date and place of birth: Citizenship: E-mail: Ariela Benigni December 16, 1955 - Bergamo, Italy Italian ariela.benigni@marionegri.it

More information

Long Term Low Dose Maintenance Chemotherapy in the Treatment of Acute Myeloid Leukemia

Long Term Low Dose Maintenance Chemotherapy in the Treatment of Acute Myeloid Leukemia Long Term Low Dose Chemotherapy in the Treatment of Acute Myeloid Leukemia Murat TOMBULO LU*, Seçkin ÇA IRGAN* * Department of Hematology, Faculty of Medicine, Ege University, zmir, TURKEY ABSTRACT In

More information

Anti-PD1 Agents: Immunotherapy agents in the treatment of metastatic melanoma. Claire Vines, 2016 Pharm.D. Candidate

Anti-PD1 Agents: Immunotherapy agents in the treatment of metastatic melanoma. Claire Vines, 2016 Pharm.D. Candidate + Anti-PD1 Agents: Immunotherapy agents in the treatment of metastatic melanoma Claire Vines, 2016 Pharm.D. Candidate + Disclosure I have no conflicts of interest to disclose. + Objectives Summarize NCCN

More information

How To Raise Money For Rare Cancer Research

How To Raise Money For Rare Cancer Research Our 2014 Impact Funding Allocations Cycle for Survival funds promise: Our donations launch and accelerate research studies and clinical trials that drive discovery. By helping fill the funding gap in rare

More information

Diagnosis of Mesothelioma Pitfalls and Practical Information

Diagnosis of Mesothelioma Pitfalls and Practical Information Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com

More information

Things You Don t Want to Miss in Multiple Myeloma

Things You Don t Want to Miss in Multiple Myeloma Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University

More information

Medical Surgical Nursing (Elsevier)

Medical Surgical Nursing (Elsevier) 1 of 6 I. The Musculoskeletal System Medical Surgical Nursing (Elsevier) 1. Med/Surg: Musculoskeletal System: The Comprehensive Health History 2. Med/Surg: Musculoskeletal System: A Nursing Approach to

More information

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods

More information

National Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be

National Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s National Cancer Institute

More information

Progressive Care Insurance for life A NEW TYPE OF INSURANCE

Progressive Care Insurance for life A NEW TYPE OF INSURANCE Progressive Care Insurance for life A NEW TYPE OF INSURANCE New Progressive Care from Sovereign Progressive Care is a type of insurance that is new to New Zealand. It s not a traditional all-or-nothing

More information

Targeted Therapy What the Surgeon Needs to Know

Targeted Therapy What the Surgeon Needs to Know Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: PS Inj - Alimta Therapeutic Class: Antineoplastic Agents Therapeutic Sub-Class: Antifolates Client: PS Inj Approval Date: 8/2/2004 Revision Date: 12/5/2006 I. BENEFIT

More information

How To Treat A Cancer With Natural Remedies

How To Treat A Cancer With Natural Remedies Mesothelioma is a devastating form of cancer that is relatively rare when compared to the incidence rates of other cancers. The word mesothelioma is derived from the English word mesothelium, which is

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

SMALL CELL LUNG CANCER

SMALL CELL LUNG CANCER Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New

More information